Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer

  • Authors:
    • Yasuhito Iseki
    • Masatsune Shibutani
    • Kiyoshi Maeda
    • Hisashi Nagahara
    • Tetsuro Ikeya
    • Kosei Hirakawa
  • View Affiliations

  • Published online on: May 26, 2017     https://doi.org/10.3892/ol.2017.6269
  • Pages: 1025-1034
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The loss of adhesion molecules is reported to be associated with tumor invasion and metastasis in numerous types of cancer. Epithelial (E)‑cadherin is an important molecule for cell‑to‑cell adhesion, while cluster of differentiation (CD)44 is an important molecule for cell‑to‑extracellular matrix adhesion. The focus of the present study was to evaluate the significance of the expression of E‑cadherin and CD44 in patients with the unresectable metastatic colorectal cancer (CRC) who are undergoing palliative chemotherapy. Formalin‑fixed, paraffin‑embedded samples were obtained from 49 patients who underwent primary tumor resection and who were receiving palliative chemotherapy for unresectable metastatic CRC. The expression of E‑cadherin and CD44 was evaluated using immunohistochemistry. The expression of E‑cadherin was not significantly associated with progression‑free survival (PFS; P=0.2825) or overall survival (OS; P=0.6617). The expression of CD44 was not associated with PFS (P=0.4365), but it did exhibit a certain level of association with OS (P=0.0699). However, the combined low expression of E‑cadherin and CD44 demonstrated a significant association with decreased PFS (P=0.0101) and OS (P=0.0009). The combined loss of E‑cadherin and CD44 expression also led to a reduction in the objective response rate and disease control rate (P=0.0076 and P=0.0294, respectively). A univariate analysis indicated that the combined low expression of E‑cadherin and CD44 (P=0.0474) and sex (P=0.0330) were significantly associated with decreased PFS, and multivariate analysis confirmed combined low expression of E‑cadherin and CD44 as an independent risk factor for decreased PFS [hazard ratio (HR), 8.276; 95% confidence interval (CI), 1.383‑43.311; P=0.0227]. Univariate and multivariate analyses also indicated that the combined low expression of E‑cadherin and CD44 expression was a significant prognostic factor for poor OS (HR, 15.118; 95% CI, 2.645‑77.490; P=0.0039). Therefore the current study suggests that the combined low expression of E‑cadherin and CD44 is an effective independent predictor of decreased chemotherapeutic outcome and survival in patients with unresectable metastatic CRC.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Iseki Y, Shibutani M, Maeda K, Nagahara H, Ikeya T and Hirakawa K: Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer. Oncol Lett 14: 1025-1034, 2017.
APA
Iseki, Y., Shibutani, M., Maeda, K., Nagahara, H., Ikeya, T., & Hirakawa, K. (2017). Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer. Oncology Letters, 14, 1025-1034. https://doi.org/10.3892/ol.2017.6269
MLA
Iseki, Y., Shibutani, M., Maeda, K., Nagahara, H., Ikeya, T., Hirakawa, K."Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer". Oncology Letters 14.1 (2017): 1025-1034.
Chicago
Iseki, Y., Shibutani, M., Maeda, K., Nagahara, H., Ikeya, T., Hirakawa, K."Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer". Oncology Letters 14, no. 1 (2017): 1025-1034. https://doi.org/10.3892/ol.2017.6269